Literature DB >> 27313696

miR-20b downregulates polymerases κ and θ in XP-V tumor cells.

Jia Guo1, Zheng Jiang2, Xiangru Li1, X I Wang1, Yan Xiao1.   

Abstract

XP-V is a subtype of Xeroderma pigmentosum diseases with typical pigmentation and cancers in sun-exposed regions. The present study investigated the role of microRNA-20b (miR-20b) in the imbalance of polymerase expression levels in XP-V tumor cells. Following software prediction results, certain miRNAs were chosen as candidate regulators for the observed imbalance in polymerases in XP-V tumor cells. Reverse transcription-quantitative polymerase chain reaction and western blot were used to test candidate miRNAs for their ability to reduce the expression of these polymerases. A luciferase reporter assay was used to further verify the western blot results. Polymerases κ and θ were expressed at lower levels in XP-V tumor cells compared to normal control cells. A positive correlation was demonstrated between miR-20b and polymerases κ and θ. It was also demonstrated that a proportion of miRNAs had no effect on polymerases κ and θ, despite the software predicting that these miRNAs would target these two polymerases. Therefore, miR-20b may be responsible for the low expression levels of polymerase κ and θ in XP-V tumor cells, which accelerated mismatch in DNA replication repairing.

Entities:  

Keywords:  POLK; POLQ; XP-V; miR-20b; xeroderma pigmentosum

Year:  2016        PMID: 27313696      PMCID: PMC4888293          DOI: 10.3892/ol.2016.4447

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  22 in total

1.  Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells.

Authors:  P Kannouche; B C Broughton; M Volker; F Hanaoka; L H Mullenders; A R Lehmann
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

Review 2.  Molecular genetics of Xeroderma pigmentosum variant.

Authors:  Alexei Gratchev; Pamela Strein; Jochen Utikal; Goerdt Sergij
Journal:  Exp Dermatol       Date:  2003-10       Impact factor: 3.960

3.  Xeroderma pigmentosum: variants with normal DNA repair and normal sensitivity to ultraviolet light.

Authors:  J E Cleaver
Journal:  J Invest Dermatol       Date:  1972-03       Impact factor: 8.551

4.  Ultraviolet mutagenesis of normal and xeroderma pigmentosum variant human fibroblasts.

Authors:  B C Myhr; D Turnbull; J A DiPaolo
Journal:  Mutat Res       Date:  1979-09       Impact factor: 2.433

5.  Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients.

Authors:  Bernard C Broughton; Agnes Cordonnier; Wim J Kleijer; Nicolaas G J Jaspers; Heather Fawcett; Anja Raams; Victor H Garritsen; Anne Stary; Marie-Françoise Avril; Francois Boudsocq; Chikahide Masutani; Fumio Hanaoka; Robert P Fuchs; Alain Sarasin; Alan R Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

Review 6.  Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription.

Authors:  M Berneburg; A R Lehmann
Journal:  Adv Genet       Date:  2001       Impact factor: 1.944

7.  Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases.

Authors:  K H Kraemer; M M Lee; J Scotto
Journal:  Arch Dermatol       Date:  1987-02

8.  DNA polymerases eta and theta function in the same genetic pathway to generate mutations at A/T during somatic hypermutation of Ig genes.

Authors:  Keiji Masuda; Rika Ouchida; Masaki Hikida; Tomohiro Kurosaki; Masayuki Yokoi; Chikahide Masutani; Mineaki Seki; Richard D Wood; Fumio Hanaoka; Jiyang O-Wang
Journal:  J Biol Chem       Date:  2007-04-20       Impact factor: 5.157

9.  Molecular analysis of DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type.

Authors:  Miki Tanioka; Taro Masaki; Ryusuke Ono; Tohru Nagano; Eriko Otoshi-Honda; Yasuhiro Matsumura; Masahiro Takigawa; Hiroki Inui; Yoshiki Miyachi; Shinichi Moriwaki; Chikako Nishigori
Journal:  J Invest Dermatol       Date:  2007-03-08       Impact factor: 8.551

10.  A novel POLH mutation causes XP-V disease and XP-V tumor proneness may involve imbalance of numerous DNA polymerases.

Authors:  Jia Guo; Guilan Zhou; Wenfeng Zhang; Yaling Song; Zhuan Bian
Journal:  Oncol Lett       Date:  2013-10-07       Impact factor: 2.967

View more
  1 in total

Review 1.  Maintenance of Genome Integrity: How Mammalian Cells Orchestrate Genome Duplication by Coordinating Replicative and Specialized DNA Polymerases.

Authors:  Ryan Barnes; Kristin Eckert
Journal:  Genes (Basel)       Date:  2017-01-06       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.